SEC Form 4 · accession 0001171843-17-005395
IMMUNOMEDICS INC · IMMU
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David M Goldenberg
Officer — See Remarks · Director
Period of report
Aug 31, 2017
Accepted (ET)
Sep 5, 2017 · 7:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000722830
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Aug 31, 2017 | S | 5,000 | $12.25 | D | 3,410,578 | I | See Footnote |
| Common StockF2 | Aug 31, 2017 | S | 5,000 | $12.50 | D | 3,405,578 | I | See Footnote |
| Common StockF2 | Sep 1, 2017 | S | 10,000 | $12.90 | D | 3,395,578 | I | See Footnote |
| Common StockF1 | holding | — | — | — | 2,410,489 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes a total of 635,935 shares held as joint tenants by the reporting person and his spouse, Ms. Cynthia L. Goldenberg, also known as Cynthia L. Sullivan, a director of the Company.
- F2Such shares are held by the reporting person's spouse, by various trusts established for the benefit of the reporting person and/or family members of the reporting person, or by a majority-owned subsidiary of the Issuer, of which the reporting person is an officer. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interests therein.
Remarks
Chief Scientific Officer and Chief Patent Officer